Anxiety StateCAASP2NCT05172076
COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor-2
An observational study of Anxiety State, run by Martin-Luther-Universität Halle-Wittenberg at 2 sites in Germany.
Trial summary
Capture of anxiety for anomalies, stillbirth and preterm labor of pregnant women during COVID-19 pandemia Read more about this study
- Who is it for?
- Ages 18 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Anxiety State
- How many people
- 276 participants
- Where
- 2 sitesGermany
- Study dates
- 1 Jan 2022to 31 Jul 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Study population: pregnant women between 33 until 37 weeks of gestations with planned labor in University Hospital of Halle or St.Elisabeth and St.Barbara Hospital Halle, Germany
Who may be able to join
- consenting ability
Who cannot join
- language barrier
- uncompleted questionary
Trial locations and contacts
2 sites in 1 country.
Germany2 sites
KH St.Elisabeth und St.Barbara
Halle, Saxony-Anhalt, 06110
University Hospital of Halle
Halle, Saxony-Anhalt, 06120
About this study
Capture of anxiety for anomalies, stillbirth and preterm labor of pregnant women during COVID-19 pandemia
- Conditions
- Anxiety State
- Medical subject headings
- Anxiety Disorders
What is being measured
The primary outcome is the main question the study is designed to answer.
anxiety for anomalies during COVID-19-pandemic and before (percentage difference in agreement to the items of the questionnaire)
Measurement of self-reported anxiety by a questionnaire and State-Trait Anxiety Inventory (STAI) and comparison (cut-off values) with different empiric studies of anxiety for anomalies in pandemics
Measured: 6 months
anxiety for stillbirths during COVID-19-pandemic and before (percentage difference in agreement to the items of the questionnaire)
Measurement of self-reported anxiety by a questionnaire and State-Trait Anxiety Inventory (STAI) and comparison (cut-off values) with different empiric studies of anxiety for stillbirths in pandemics
Measured: 6 months
anxiety for preterm labour during COVID-19-pandemic and before (percentage difference in agreement to the items of the questionnaire)
Measurement of self-reported anxiety by a questionnaire and State-Trait Anxiety Inventory (STAI) and comparison (cut-off values) with different empiric studies of anxiety for preterm labour in pandemics
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Dec 2021
- Study start1 Jan 2022
- Primary completion31 Jul 2022
- Study completion31 Jul 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Anxiety StateStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 276 participants (actual)
Sponsor and investigators
- Lead sponsor
- Martin-Luther-Universität Halle-Wittenberg
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Marcus Riemer, MD, Martin-Luther-Universität Halle-Wittenberg
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05172076
- Sponsor's protocol ID
- 2021-228
- Acronym
- CAASP2
- Status last verified
- Nov 2023
- First submitted
- 25 Dec 2021
- Last updated
- 29 Nov 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 29 Nov 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor-2
- ClinicalTrials.gov ID
- NCT05172076
- Acronym / sponsor ID
- CAASP2 / 2021-228
- Conditions
- Anxiety State
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 276 participants (actual)
- Lead sponsor
- Martin-Luther-Universität Halle-WittenbergUniversity, hospital or other
- Study start
- 1 Jan 2022 (actual)
- Primary completion
- 31 Jul 2022 (actual)
- Study completion
- 31 Jul 2023 (actual)
- First posted
- 29 Dec 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Capture of anxiety for anomalies, stillbirth and preterm labor of pregnant women during COVID-19 pandemia
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- pregnant women between 33 until 37 weeks of gestations with planned labor in University Hospital of Halle or St.Elisabeth and St.Barbara Hospital Halle, Germany
Key inclusion criteria (1 listed)
- consenting ability
Key exclusion criteria (2 listed)
- language barrier
- uncompleted questionary
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
anxiety for anomalies during COVID-19-pandemic and before (percentage difference in agreement to the items of the questionnaire)
Time frame: 6 months
Measurement of self-reported anxiety by a questionnaire and State-Trait Anxiety Inventory (STAI) and comparison (cut-off values) with different empiric studies of anxiety for anomalies in pandemics
anxiety for stillbirths during COVID-19-pandemic and before (percentage difference in agreement to the items of the questionnaire)
Time frame: 6 months
Measurement of self-reported anxiety by a questionnaire and State-Trait Anxiety Inventory (STAI) and comparison (cut-off values) with different empiric studies of anxiety for stillbirths in pandemics
anxiety for preterm labour during COVID-19-pandemic and before (percentage difference in agreement to the items of the questionnaire)
Time frame: 6 months
Measurement of self-reported anxiety by a questionnaire and State-Trait Anxiety Inventory (STAI) and comparison (cut-off values) with different empiric studies of anxiety for preterm labour in pandemics
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Nov 2023.
- First Trial CAASP NCT04568551Link provided by the sponsor.
- Individual participant dataSharing planned: Undecided
Related trials for Anxiety State
Not yet recruiting
The Effect of Skin-to-Skin Contact on Pain and Anxiety During Episiotomy Repair
Episiotomy, Pain
Active, not recruiting
HRVB for Stress and Anxiety During Dentistry Students' Clinical Transition
Stress (Psychology), Anxiety
Not yet recruiting
Virtual Reality for Anxiety and Birth Satisfaction During Elective Cesarean Section
Anxiety, Cesarean Section
Not yet recruitingObservational study
Ecological Momentary Assessment of State-Dependent Decision-Making and Metacognition Across a Psychopathology Continuum
Depression, Anxiety
Not yet recruiting
Acupuncture Combined With Transcutaneous Electrical Acupoint Stimulation for Constipation-Predominant Irritable Bowel Syndrome With Anxiety State
IBS, Constipation Predominant, Anxiety State
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Anxiety State, run by Martin-Luther-Universität Halle-Wittenberg at 2 sites in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
anxiety for anomalies during COVID-19-pandemic and before (percentage difference in agreement to the items of the questionnaire) (time frame: 6 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Nov 2023.